Cargando…

A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes

PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietar...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidl, Doreen, Howorka, Kinga, Szegedi, Stephan, Stjepanek, Kristina, Puchner, Stefan, Bata, Ahmed, Scheschy, Ulrike, Aschinger, Gerold, Werkmeister, René M., Schmetterer, Leopold, Garhofer, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190578/
https://www.ncbi.nlm.nih.gov/pubmed/32355442
_version_ 1783527710387077120
author Schmidl, Doreen
Howorka, Kinga
Szegedi, Stephan
Stjepanek, Kristina
Puchner, Stefan
Bata, Ahmed
Scheschy, Ulrike
Aschinger, Gerold
Werkmeister, René M.
Schmetterer, Leopold
Garhofer, Gerhard
author_facet Schmidl, Doreen
Howorka, Kinga
Szegedi, Stephan
Stjepanek, Kristina
Puchner, Stefan
Bata, Ahmed
Scheschy, Ulrike
Aschinger, Gerold
Werkmeister, René M.
Schmetterer, Leopold
Garhofer, Gerhard
author_sort Schmidl, Doreen
collection PubMed
description PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietary supplement (Oculofolin, Aprofol AG, Switzerland) containing 900 µg L‑methylfolate (levomefolate calcium or [6S]-5-methyltetrahydrofolic acid, calcium salt), methylcobalamin, and other ingredients for three consecutive months. The patients’ plasma homocysteine concentration and retinal blood flow were assessed at baseline and after three months of folate intake. Retinal blood flow was measured using a custom-built dual-beam Doppler optical coherence tomography (OCT) system. In addition, flicker-induced retinal vasodilatation was assessed by means of a commercially available dynamic vessel analyzer (IMEDOS, Jena, Germany). RESULTS: Supplementation was well tolerated by all patients. After three months, plasma homocysteine concentration significantly decreased from 14.2 ± 9.3 to 9.6 ± 6.6 µmol/L (p < 0.001). In addition, a tendency toward an increased total retinal blood flow from 36.8 ± 12.9 to 39.2 ± 10.8 µl/min was observed, but this effect did not reach the level of significance (p = 0.11). Supplementation had no effect on retinal vessel diameter or flicker-induced vasodilatation. CONCLUSIONS: The present data show that a three-month intake of a dietary supplement containing methylfolate can significantly reduce blood homocysteine levels in patients with diabetes. This is of importance because higher homocysteine plasma levels have been found to be associated with an increased risk of vascular associated systemic diseases and eye diseases. Whether systemic methylfolate supplementation affects retinal perfusion must be studied in a larger population.
format Online
Article
Text
id pubmed-7190578
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-71905782020-04-30 A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes Schmidl, Doreen Howorka, Kinga Szegedi, Stephan Stjepanek, Kristina Puchner, Stefan Bata, Ahmed Scheschy, Ulrike Aschinger, Gerold Werkmeister, René M. Schmetterer, Leopold Garhofer, Gerhard Mol Vis Research Article PURPOSE: The aim of the present study was to investigate the effect of a three-month dietary supplementation with a methylfolate formulation on homocysteine plasma concentrations and ocular blood flow parameters in patients with diabetes. METHODS: Twenty-four patients with diabetes received a dietary supplement (Oculofolin, Aprofol AG, Switzerland) containing 900 µg L‑methylfolate (levomefolate calcium or [6S]-5-methyltetrahydrofolic acid, calcium salt), methylcobalamin, and other ingredients for three consecutive months. The patients’ plasma homocysteine concentration and retinal blood flow were assessed at baseline and after three months of folate intake. Retinal blood flow was measured using a custom-built dual-beam Doppler optical coherence tomography (OCT) system. In addition, flicker-induced retinal vasodilatation was assessed by means of a commercially available dynamic vessel analyzer (IMEDOS, Jena, Germany). RESULTS: Supplementation was well tolerated by all patients. After three months, plasma homocysteine concentration significantly decreased from 14.2 ± 9.3 to 9.6 ± 6.6 µmol/L (p < 0.001). In addition, a tendency toward an increased total retinal blood flow from 36.8 ± 12.9 to 39.2 ± 10.8 µl/min was observed, but this effect did not reach the level of significance (p = 0.11). Supplementation had no effect on retinal vessel diameter or flicker-induced vasodilatation. CONCLUSIONS: The present data show that a three-month intake of a dietary supplement containing methylfolate can significantly reduce blood homocysteine levels in patients with diabetes. This is of importance because higher homocysteine plasma levels have been found to be associated with an increased risk of vascular associated systemic diseases and eye diseases. Whether systemic methylfolate supplementation affects retinal perfusion must be studied in a larger population. Molecular Vision 2020-04-24 /pmc/articles/PMC7190578/ /pubmed/32355442 Text en Copyright © 2020 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Schmidl, Doreen
Howorka, Kinga
Szegedi, Stephan
Stjepanek, Kristina
Puchner, Stefan
Bata, Ahmed
Scheschy, Ulrike
Aschinger, Gerold
Werkmeister, René M.
Schmetterer, Leopold
Garhofer, Gerhard
A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title_full A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title_fullStr A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title_full_unstemmed A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title_short A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
title_sort pilot study to assess the effect of a three-month vitamin supplementation containing l-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190578/
https://www.ncbi.nlm.nih.gov/pubmed/32355442
work_keys_str_mv AT schmidldoreen apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT howorkakinga apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT szegedistephan apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT stjepanekkristina apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT puchnerstefan apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT bataahmed apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT scheschyulrike apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT aschingergerold apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT werkmeisterrenem apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT schmettererleopold apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT garhofergerhard apilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT schmidldoreen pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT howorkakinga pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT szegedistephan pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT stjepanekkristina pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT puchnerstefan pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT bataahmed pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT scheschyulrike pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT aschingergerold pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT werkmeisterrenem pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT schmettererleopold pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes
AT garhofergerhard pilotstudytoassesstheeffectofathreemonthvitaminsupplementationcontaininglmethylfolateonsystemichomocysteineplasmaconcentrationsandretinalbloodflowinpatientswithdiabetes